Lepu Bio is a Innovation-Driven Biopharmaceutical Company.
Lepu Bio they have developed an oncology-focused pipeline of drug candidates, including ADCs, oncolytic virus drugs, and immunotherapies at clinical and pre-clinical stages.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 6, 2020 | Series B | ¥1.29B | 2 | — | — | Detail |
Jul 2, 2019 | Series A | ¥0.90B | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
State New Central Enterprises Operating Investment Fund | — | Series B |
Haitong Innovation Capital Management | — | Series B |
Sumin Investment | — | Series A |